Editorial
 THE ACTION ON SEMLER   
 Wednesday, May 04, 2016 
 Data integrity issue has been a matter of serious concern for India‚Äôs top pharmaceutical companies for some years now affecting their exports to the US and European Union, the two key export destinations of generic drugs. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]Ferring Pharma gets EU approval for Nocdurna to treat nocturia due to idiopathic nocturnal polyuria in adults
17:00  [IST]US FDA approves Boston Scientific's IntellaNav XP and IntellaNav MiFi XP navigation-enabled ablation catheters
16:35  [IST]Linde introduces light-weight LIV medical oxygen cylinder
16:30  [IST]Sequenom enters in-network contracts with Anthem Blue Cross and Blue Shield
16:25  [IST]Lanxess to acquire clean and disinfect business of US-based Chemours for Euro 210 million
16:00  [IST]BioNovus, University of Kansas Medical Center's IAMI collaborate to develop new drugs, diagnostics & medical devices
more news >>
TOP NEWS
08:00  [IST]DBT to begin research to develop innovative, field-applicable & cost-effective diagnostic biomarkers for TB
08:00  [IST]KSRPA insists on amendment of D&C Rules to mandate installation of air conditioner unit across pharmacy outlets
08:00  [IST]Clinical studies on metronomic therapy needed to offer affordable cancer treatment in LMICs: Experts
08:00  [IST]Pharma industry needs to use patent information to reduce R&D costs: Bindu Sharma
08:00  [IST]Women students of Pharm D in Kerala launch SAHELI to educate rural women on family planning
08:00  [IST]DST to begin research in area of cognitive science under CSR initiative
more news >>
YESTERDAY'S NEWS
18:00  [IST]Essential Medical seeks CE Mark for MANTA large bore vascular closure device
17:30  [IST]United Cargo to enhance TempControl service by accepting Envirotainer RAP e2 temperature-controlled container
17:00  [IST]Oculus Innovative introduces Ceramax Skin Barrier Cream in US
16:45  [IST]Asthmatic women may face challenges in pregnancy than others
16:35  [IST]Sun Pharma's two phase-3 trials of tildrakizumab in patients with moderate-to-severe plaque psoriasis meets primary endpoints
14:30  [IST]ICGEB, Sun Pharma collaborate to develop botanical drug for dengue
more news >>
INTERVIEW  
Need for screening patients with high risk of aortic disease: Tony Semedo
Medtronic Tony Semedo, Senior vice president
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the ban on 344 FDC drugs by the Union Health Ministry came all of a sudden as is being argued by the industry?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |